Management of patients with ovarian cancer in the COVID‐19 era

At the beginning of 2020, coronavirus disease 2019 (COVID‐19) spreads worldwide. Patients with ovarian cancer should be considered at high‐risk of developing severe morbidity related to COVID‐19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the m...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Surg Oncol
Auteurs principaux: Bogani, Giorgio, Casarin, Jvan, Pinelli, Ciro, Di Donato, Violante, Bosio, Sara, Ruisi, Simona, Brusadelli, Claudia, Guerrisi, Rocco, Sarpietro, Giuseppe, Ditto, Antonino, Ghezzi, Fabio, Raspagliesi, Francesco
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Commentary
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300981/
https://ncbi.nlm.nih.gov/pubmed/32476155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.26057
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires